Galectin Therapeutics Inc. (GALT)

[biotech2010]

It was in the 10K, nothing new:

http://www.sec.gov/Archives/edgar/data/1133416/999999999716023271/filename1.pdf

Galectin Therapeutics, Inc. submitted an application under Rule 24b-2 requesting confidential treatment for information it excluded from the Exhibits to a Form 10-K filed on March 15, 2016, as amended.
Based on representations by Galectin Therapeutics, Inc. that this information qualifies as confidential commercial or financial information under the Freedom ofInformation Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified:
Exhibit 10.50 through May 1, 2018

From the 10K:

10.50** Project Addendum Modification, dated March 11, 2016, by and between Galectin Therapeutics, Inc. and PPD Development, L.P.***

On March 11, 2016, we entered into a Project Addendum Modification with PPD Development, L.P. ("PPD") amending our Project Addendum to Master Services Agreement for clinical management services, which we entered into on March 6, 2015. Pursuant to the Project Addendum Modification, the parties have revised the timeline, the budget and payment schedule for the trial.

This took me 5 minutes to research, I don't understand how anyone can invest in a company without the interest in finding out their own answers.